CXMedUS, Inc. – FDA 483, Apr 6, 2023
CXMEDUS, Inc. in Grand Blanc, MI, a medical device establishment, was inspected by the FDA, resulting in five observations. The inspection revealed significant deficiencies in the firm's quality system, primarily concerning the lack of documented and implemented procedures for complaint handling, medical device reporting, corrective and preventive actions, supplier management, and incoming product acceptance. These issues indicate a fundamental breakdown in the firm's ability to ensure product quality and compliance with regulatory requirements.
ID · a953cf5d-e613-45b8-a3a8-aeb008b4d457
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.